Determination of the cutoff point of the absolute value of MGMTmRNA for predicting the therapeutic resistance to temozolomide in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determination of the cutoff point of the absolute value of MGMTmRNA for predicting the therapeutic resistance to temozolomide in glioblastoma

Published:2020-11 Issue:5 Volume:64 Page:
ISSN:0390-5616
Container-title:Journal of Neurosurgical Sciences
language:
Short-container-title:J Neurosurg Sci

Author:

Tanaka Satoshi,Akimoto Jiro,Narita Yoshitaka

Publisher

Edizioni Minerva Medica

Subject

Clinical Neurology,Surgery

Link

https://www.minervamedica.it/pdf.php?cod=R38Y2020N05A0434

Reference26 articles.

1. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation

4. Multifaceted resistance of gliomas to temozolomide;Bocangel DB;Clin Cancer Res,2002

5. Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive pharmacogenomics characterization of temozolomide response in gliomas;European Journal of Pharmacology;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP